Cutler Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,600
Closed -$2K 5654
2017
Q3
$2K Buy
1,600
+1,200
+300% +$61.3K ﹤0.01% 5134
2017
Q2
$1K Buy
+400
New +$21.4K ﹤0.01% 5978
2016
Q4
Sell
-2,000
Closed -$6K 7106
2016
Q3
$6K Buy
2,000
+1,500
+300% +$75.9K ﹤0.01% 4784
2016
Q2
$2K Buy
+500
New +$27.5K ﹤0.01% 5714
2016
Q1
Sell
-2,300
Closed -$3K 6992
2015
Q4
$3K Buy
+2,300
New +$114K ﹤0.01% 5338

Other funds holding PBH

Cutler Group's PBH Position: Q4 2017 in Review

Cutler Group sold out of Prestige Consumer Healthcare (PBH) in Q4 2017, closing a stake of 791 shares — an estimated $39K sold.

Cutler Group first reported a position in PBH in Q4 2015 and held it in 6 quarters. The position peaked at $124K in Q1 2016. 251 funds tracked by Wall St. Rank hold PBH as of Q4 2017.

  • Cutler Group reported no remaining Prestige Consumer Healthcare position as of Q4 2017 after selling out during the quarter.
  • Cutler Group sold 791 Prestige Consumer Healthcare shares in Q4 2017, an estimated $39K.
  • Cutler Group first reported a position in Prestige Consumer Healthcare in Q4 2015 and held it in 6 quarters.
  • Cutler Group's Prestige Consumer Healthcare position peaked at $124K in Q1 2016.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.